FNY Investment Advisers’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

FNY Investment Advisers’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,730	Closed	-$130K	–	963
2022 Q2	$130K	Buy	+1,730	New	+$76.9K	0.1%	136
2019 Q4	–	Sell	-3,150	Closed	-$118K	–	1144
2019 Q3	$118K	Buy	+3,150	New	+$137K	0.04%	265

FNY Investment Advisers's TPTX Position: Q3 2022 in Review

FNY Investment Advisers sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 1,730 shares — an estimated $130K sold.

FNY Investment Advisers first reported a position in TPTX in Q3 2019 and held it in 2 quarters. The position peaked at $130K in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

FNY Investment Advisers reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
FNY Investment Advisers sold 1,730 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $130K.
FNY Investment Advisers first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q3 2019 and held it in 2 quarters.
FNY Investment Advisers's Turning Point Therapeutics, Inc. Common Stock position peaked at $130K in Q2 2022.
0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on FNY Investment Advisers's 13F filing for Q3 2022, filed 19 Oct 2022.